|
Hematopathology Subdivision Report
 |
By
Kojo S. J. Elenitoba-Johnson, MD
Chair, Hematopathology Subdivision
e-mail: kojoelen@umich.edu |
We
have now finalized the Hematopathology sessions for the 2009
Annual Meeting in Kissimmee, Florida. The program will
include discussions involving multiple topics of relevance
to the field of Molecular Hematopathology. The
Hematopathology sessions will be kicked off by an Early Bird
Session on Friday (November 20) given by Dr. Bryan Betz
addressing the prognostic implications of acquired mutations
in acute myelogenous leukemias.
The
Hematopathology Session will include work from AMP members
and features five platform (oral) presentations representing
a variety of topics ranging from array based karyotyping to
detection of diagnostically and prognostically important
mutations in hematopoietic malignancies. These presentations
selected from a pool of high quality abstracts will be
presented at the Meeting, and will be of interest to the
Hematopathology community. We are anticipating an exciting
and interactive session.
In the
Workshop “Acquired Mutations in
Myeloproliferative Diseases,” Josef Prchal will
speak about somatic mutations and uniparental disomy in
Philadelphia chromosome negative myeloprolifereative
diseases. Rebecca McClure will address practical
issues associated with the detection of mutations in JAK2
and other genes in chronic myeloproliferative disorders. The
Plenary Sessions will feature work from Laura Pasqualucci
discussing the role of mutations genes in the NFκB pathway
in the pathogenesis of malignant lymphomas, and Vu Ngo who
will discuss the impact of large-scale RNAi Achilles-heel
screens in the discovery of pathogenetically-relevant
therapeutic targets in diffuse large B-cell lymphoma.
Overall,
we anticipate engaging sessions addressing topical issues
with rich educational content. Timothy Greiner and I
welcome opportunities to discuss proposals for new
initiatives to be considered for future programs in order to
continue the tradition of strong molecular Hematopathology
sessions at AMP.
In
closing, I am grateful to the membership for your confidence
in granting me the opportunity to Chair the AMP
Hematopathology Subdivision. I look forward to further
active participation in our organization and meeting many of
you at the Annual Meeting as we hand over the baton to the
able Tim Greiner who will serve as your next Chair. |